Wegovy: USD ~8.2B Key Peptide Products: Semaglutide (Ozempic, Wegovy, Rybelsus), insulin degludec (Tresiba), liraglutide (Victoza, Saxenda), CagriSema (pipeline), semaglutide 7.2mg (pipeline) Therapeutic Segments: Diabetes Care (GLP-1, Insulins)
Patients with hepatic impairment
Materials and Methods Experimental Animals and Groups In our study, we raised 120 specific pathogen-free (SPF) grade Wistar male rats (180 20 g weight and 24 weeks old, which is equivalent to 1820 years old in humans) provided by the Experimental Animal Center of the 940th Hospital of Joint Logistics Support force of Chinese Peoples Liberation Army (licence: SCXY (Military) 20120020)
, L-
[DOI] [PubMed] [Google Scholar] 24.Alatrach M., Agyin C., Adams J., Chilton R., Triplitt C., DeFronzo R.A., Cersosimo E
Irrespective of whether a patent in a patent family was a continuation, continuation-in-part, divisional application, or linked by a terminal disclaimer in terms of its expiry date, it was counted as a distinct patent